These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29348549)

  • 1. Preoperative anemia in colorectal cancer: relationships with tumor characteristics, systemic inflammation, and survival.
    Väyrynen JP; Tuomisto A; Väyrynen SA; Klintrup K; Karhu T; Mäkelä J; Herzig KH; Karttunen TJ; Mäkinen MJ
    Sci Rep; 2018 Jan; 8(1):1126. PubMed ID: 29348549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normocytic anaemia is associated with systemic inflammation and poorer survival in patients with colorectal cancer treated with curative intent.
    McSorley ST; Johnstone M; Steele CW; Roxburgh CSD; Horgan PG; McMillan DC; Mansouri D
    Int J Colorectal Dis; 2019 Mar; 34(3):401-408. PubMed ID: 30515556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative data on red cell measures of iron status and their relation to the magnitude of the systemic inflammatory response and survival in patients with colorectal cancer.
    McSorley ST; Tham A; Steele CW; Dolan RD; Roxburgh CS; Horgan PG; McMillan DC
    Eur J Surg Oncol; 2019 Jul; 45(7):1205-1211. PubMed ID: 30850153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.
    Inoue Y; Iwata T; Okugawa Y; Kawamoto A; Hiro J; Toiyama Y; Tanaka K; Uchida K; Mohri Y; Miki C; Kusunoki M
    Oncology; 2013; 84(2):100-7. PubMed ID: 23147449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of preoperative anaemia and anaemic subtype on patient outcome in colorectal cancer.
    Tokunaga R; Nakagawa S; Miyamoto Y; Ohuchi M; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Yoshida N; Baba H
    Colorectal Dis; 2019 Jan; 21(1):100-109. PubMed ID: 30230148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases.
    Shimura T; Toiyama Y; Saigusa S; Imaoka H; Okigami M; Fujikawa H; Hiro J; Kobayashi M; Ohi M; Araki T; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    Int J Clin Oncol; 2017 Aug; 22(4):758-766. PubMed ID: 28299463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between different types of preoperative anemia and tumor characteristics, systemic inflammation, and survival in colorectal cancer.
    Zhou C; Ma H; Wang G; Liu Y; Li B; Niu J; Zhao Y; Wang G
    PeerJ; 2023; 11():e16293. PubMed ID: 38144195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
    Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
    Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
    Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet count, aspirin use, and characteristics of host inflammatory responses in colorectal cancer.
    Väyrynen JP; Väyrynen SA; Sirniö P; Minkkinen I; Klintrup K; Karhu T; Mäkelä J; Herzig KH; Karttunen TJ; Tuomisto A; Mäkinen MJ
    J Transl Med; 2019 Jun; 17(1):199. PubMed ID: 31196200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
    Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer and markers of anemia.
    Schneider C; Bodmer M; Jick SS; Meier CR
    Eur J Cancer Prev; 2018 Nov; 27(6):530-538. PubMed ID: 28692587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
    Rossi S; Basso M; Strippoli A; Schinzari G; D'Argento E; Larocca M; Cassano A; Barone C
    Clin Colorectal Cancer; 2017 Dec; 16(4):264-274. PubMed ID: 28412137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The yield of colorectal cancer among fast track patients with normocytic and microcytic anaemia.
    Panagiotopoulou IG; Fitzrol D; Parker RA; Kuzhively J; Luscombe N; Wells AD; Menon M; Bajwa FM; Watson MA
    Ann R Coll Surg Engl; 2014 May; 96(4):289-93. PubMed ID: 24780021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Burden of Modified Glasgow Prognostic Scale in Colorectal Cancer.
    Okugawa Y; Shirai Y; Toiyama Y; Saigusa S; Hishida A; Yokoe T; Tanaka K; Tanaka M; Yasuda H; Fujikawa H; Hiro J; Kobayashi M; Araki T; Inoue Y; McMillan DC; Kusunoki M; Miki C
    Anticancer Res; 2018 Mar; 38(3):1599-1610. PubMed ID: 29491091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.
    Sirniö P; Tuomisto A; Tervahartiala T; Sorsa T; Klintrup K; Karhu T; Herzig KH; Mäkelä J; Karttunen TJ; Salo T; Mäkinen MJ; Väyrynen JP
    Br J Cancer; 2018 Jul; 119(2):213-219. PubMed ID: 29808017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging the tumor and staging the host: A two centre, two country comparison of systemic inflammatory responses of patients undergoing resection of primary operable colorectal cancer.
    Park JH; Ishizuka M; McSorley ST; Kubota K; Roxburgh CSD; Nagata H; Takagi K; Iwasaki Y; Aoki T; Horgan PG; McMillan DC
    Am J Surg; 2018 Sep; 216(3):458-464. PubMed ID: 28967380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer.
    Sirniö P; Väyrynen JP; Klintrup K; Mäkelä J; Mäkinen MJ; Karttunen TJ; Tuomisto A
    Sci Rep; 2017 Jul; 7(1):5374. PubMed ID: 28710487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival.
    Sirniö P; Väyrynen JP; Klintrup K; Mäkelä J; Karhu T; Herzig KH; Minkkinen I; Mäkinen MJ; Karttunen TJ; Tuomisto A
    Br J Cancer; 2019 Jan; 120(2):238-246. PubMed ID: 30563990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.